6533b82ffe1ef96bd1296222
RESEARCH PRODUCT
Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, and Lactobacillus delbrueckii LDD01) in patients undergoing bowel preparation.
L. BonavinaA. ArianiL. FicanoD. IannuzzielloL. PasqualeS. E. AragonaL. DragoG. CiprandiOn Digestive Disorders I. S. G. Annicchiarico RaffaeleBucci AntongiulioArrigo ArrigoniStefano BargiggiaPaolo Beretta Berni Canani MarcellaAntonino BertinoFilippo BovaGiampaolo BresciCarmelo BudaSalvatore CamilleriSte-fania CaronnaGregorio Cavallo Chahin Nabil JamilVirgilio ClaraSelvaggio CorradoGiovanni CozzoliUgo CrescenziRaimondo DarioFrancesco D’arpaAntonello DattolaDavide DeianaArmando Dell’anna Di Fenza Sergio Di Lorenzo Fernando Di Napoli An-geloVittorio D’onofrioGiovanni FerriniDomenico FerrulliRoberto FinizioNicola Gaffuri Garcea Maria RitaSalvatore GenovaPietro GiorgioMaurizio GiovannoneGiuliana GiuseppeGiovanni GuarnieriRenzo GullottaGiuseppe LeonardiGiovanni MagrìTammaro MaistoMariagrazia MancinoGianpiero ManesSantino MarchiRenato MarinMaria MarinoManuele MazziFrancesca Menasci Morabito Lo Prete AntonioFrancesca Murer Neri Bortoluzzi FrancescoSocrate PallioAntonio PalmaDa-vide PardocchiAntonio Pinto Pio Palieri AntonioAntonio PisaniAntonello PriviteraRaffaela PulitanòRossella PumpoFrancesco QuatraroIvana RaguzziCesarina RainisioGiulia RazzoliniOlimpia RevelloNicita RinaldoGiuseppe RivelliniGuidorenato SabadiniMarcello SalviaGennaro SarrantonioEdoardo SavarinoAntonella ScarcelliPietro SchettinoAngelo SchicchiLuigi SchiffinoLuca SediariEndrit ShainiCristiano SpadaFernando SpinelliLorenza TifiClaudio TrovatoRoberto VassalloMaurizio VintiFrancesca ZappatoreClaudio. Zullisubject
MaleLactobacillus delbrueckiigut microbiotaProbioticsColonoscopyMiddle AgedLactobacillusPreoperative Carebowel preparationDysbiosisHumansFemaleOriginal Articlesurveybowel preparation gut microbiota colonoscopy probiotics surveyLactobacillus plantarumdescription
Bowel preparation (BP) for colonoscopy induces significantly changes in gut microbiota and elicit intestinal symptoms. Impaired microbiota causes an intestinal dysbiosis. Consequently, probiotics may counterbalance the disturbed microbiota after BP. The current survey evaluated the efficacy and safety of Abincol®,an oral nutraceuticalcontaining a probiotic mixture with Lactobacillus plantarum LP01 (1 billion of living cells), Lactobacillus lactis subspecies cremoris LLC02 (800 millions of living cells), and Lactobacillus delbrueckii LDD01 (200 millions of living cells), in 2,979 outpatients (1,579 males and 1,400 females, mean age 56 years) undergoing BP. Patients took 1 stick/daily for 4 weeks after colonoscopy. Abincol® significantly diminished the presence and the severity of intestinal symptoms and improved stool form. In conclusion, the current survey suggests that Abincol® may be considered an effective and safe therapeutic option in the management of patients undergoing BP. (www.actabiomedica.it)
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2019-07-02 | Acta bio-medica : Atenei Parmensis |